Quest Diagnostics (DGX) Oct IV elevated at 43 into Q3 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Quest Diagnostics (DGX) PT Lowered to $103 at Mizuho Securities
October 19, 2017 5:19 PM EDTMizuho Securities lowered its price target on Quest Diagnostics (NYSE: DGX) to $103.00 (from $122.00) while maintaining a Buy rating. Analyst Ann Hynes updated 2018 and 2019 adjusted EPS estimates, both decreasing by $0.10 related to the proposed PAMA rule released in September.
Mizuho Securities did not... More
